
  
    
      
        Background_NNP
        The_DT established_VBN associations_NNS between_IN the_DT highly_RB
        polymorphic_JJ MHC_NNP loci_NN and_CC several_JJ human_JJ diseases_NNS have_VBP
        elucidated_JJ the_DT possible_JJ genetic_JJ basis_NN of_IN their_PRP$
        predisposition_NN ._. [_NN 1_CD 2_CD ]_NN From_IN a_DT classical_JJ approach_NN of_IN
        mapping_VBG an_DT MHC_NNP allele_NN with_IN a_DT particular_JJ disease_NN ,_, the_DT focus_NN
        has_VBZ shifted_VBN to_TO determine_VB the_DT specific_JJ peptides_NNS presented_VBN to_TO
        MHC_NNP molecules_NNS with_IN clearly_RB defined_VBN sequences_NNS ._. Different_NNP MHC_NNP
        alleles_NNS recognize_VBP different_JJ peptides_NNS and_CC the_DT binding_JJ
        probabilities_NNS of_IN natural_JJ and_CC non-natural_JJ peptide_NN ligands_NNS to_TO
        MHC_NNP molecules_NNS are_VBP non-static_JJ ._. [_NN 3_CD ]_NN The_DT current_JJ challenge_NN
        is_VBZ to_TO screen_VB the_DT sequences_NNS for_IN candidate_NN MHC_NNP ligands_NNS or_CC
        tissue_NN specific_JJ disease-inducing_JJ peptides_NNS as_IN relevant_JJ
        T-_NNP cell_NN epitopes_NNS ._. Identification_NNP of_IN T-_NNP cell_NN epitopes_NNS
        associated_VBN with_IN a_DT particular_JJ disease_NN can_MD lead_VB to_TO the_DT
        development_NN of_IN potential_JJ peptide_NN vaccines_NNS ._. [_NN 4_CD ]_NN Such_JJ
        epitopes_NNS also_RB find_VBP application_NN in_IN tetramer_NN staining_VBG as_IN
        powerful_JJ immuno-markers_JJ for_IN estimating_VBG antigen_NN specific_JJ T_NN
        cells_NNS during_IN pathogenesis_NNS ._. [_NN 5_CD ]_NN Establishing_VBG MHC_NNP binding_JJ
        differences_NNS to_TO mHags_NNS (_( minor_JJ histocompatibility_NN antigen_NN
        peptides_NNS )_) will_MD guide_VB the_DT interpretation_NN of_IN HA-_NNP 1_CD related_VBN
        GvHD_NNP (_( Graft_NNP vs_NNS Host_NNP Disease_NNP )_) data_NNS in_IN the_DT context_NN of_IN
        different_JJ MHC_NNP alleles_NNS ._. [_NN 6_CD 7_CD ]_NN However_RB ,_, additional_JJ
        parameters_NNS describing_VBG the_DT mechanism_NN of_IN peptide_NN processing_NN ,_,
        peptide_NN transport_NN ,_, loading_NN of_IN peptide_NN to_TO MHC_NNP molecules_NNS and_CC
        presentation_NN of_IN MHC-peptide_NNP complexes_NNS for_IN inspection_NN by_IN T_NN
        cells_NNS are_VBP crucial_JJ in_IN epitope_NN selection_NN ._. [_NN 8_CD 9_CD ]_NN
        The_DT successful_JJ sampling_VBG of_IN short_JJ peptides_NNS from_IN a_DT pool_NN of_IN
        viral_JJ or_CC bacterial_JJ protein_NN sequences_NNS using_VBG MHC-peptide_NNP
        binding_JJ prediction_NN programs_NNS depends_VBZ on_IN the_DT accuracy_NN of_IN
        their_PRP$ algorithms_NNS ._. A_DT number_NN of_IN computational_NN methods_NNS have_VBP
        been_VBN developed_VBN for_IN the_DT prediction_NN of_IN MHC-peptide_NNP binding_JJ [_NN
        10_CD 11_CD 12_CD 13_CD 14_CD 15_CD 16_CD 17_CD 18_CD 19_CD 20_CD 21_CD 22_CD 23_CD 24_CD 25_CD 26_CD ]_NN ._.
        Using_VBG data_NNS from_IN allele_NN specific_JJ binding_JJ experiments_NNS -_:
        sequence_NN binding_JJ motif_NN analysis_NN [_NN 10_CD ]_NN ;_: weight_NN matrices_NNS [_NN
        11_CD 12_CD 13_CD ]_NN ,_, ANN_NNP [_NN 14_CD 15_CD 16_CD ]_NN ,_, HMM_NNP [_NN 17_CD ]_NN and_CC iterative_JJ
        stepwise_NN discriminant_NN meta-algorithm_JJ [_NN 18_CD ]_NN have_VBP been_VBN
        applied_VBN for_IN predictions_NNS ._. These_DT algorithms_NNS have_VBP been_VBN used_VBN to_TO
        predict_VB peptide_NN binding_JJ to_TO very_RB few_JJ MHC_NNP molecules_NNS because_IN
        binding_JJ data_NNS is_VBZ not_RB available_JJ for_IN many_JJ alleles_NNS ._. Protein_NNP
        threading_VBG [_NN 19_CD 20_CD 21_CD 22_CD ]_NN and_CC side-chain_JJ packing_NN [_NN 23_CD 24_CD 25_CD
        26_CD ]_NN techniques_NNS have_VBP been_VBN applied_VBN in_IN molecular_JJ mechanics_NNS
        based_VBD MHC-peptide_NNP binding_JJ predictions_NNS ._. The_DT molecular_JJ
        mechanics_NNS based_VBD binding_JJ prediction_NN approach_NN can_MD be_VB
        extrapolated_VBN to_TO a_DT wide_JJ range_NN of_IN MHC_NNP molecules_NNS defined_VBN by_IN
        sequence_NN nomenclature_NN ._. The_DT prediction_NN of_IN peptide_NN binding_JJ to_TO
        MHC_NNP molecules_NNS is_VBZ described_VBN as_IN a_DT two-fold_JJ problem_NN ,_, the_DT first_JJ
        being_NN protein_NN folding_VBG [_NN 27_CD ]_NN and_CC the_DT second_JJ molecular_JJ
        interactions_NNS ._. [_NN 28_CD 29_CD 30_CD ]_NN The_DT problem_NN of_IN packing_VBG
        sidechains_NNS using_VBG a_DT near_IN native_JJ backbone_NN has_VBZ been_VBN solved_VBN ._. [_NN
        27_CD ]_NN Generating_NNP peptide_NN backbones_NNS sufficiently_RB close_RB to_TO the_DT
        native_JJ backbone_NN to_TO allow_VB packing_VBG algorithms_NNS is_VBZ still_RB a_DT
        challenge_NN ._. [_NN 31_CD ]_NN Hence_RB ,_, methods_NNS for_IN predicting_VBG backbone_NN
        conformation_NN are_VBP not_RB as_RB developed_VBN as_IN that_DT for_IN
        sidechains_NNS ._.
        Data_NNS for_IN a_DT number_NN of_IN A_DT *_NN 0201_CD ,_, A_DT *_NN 6801_CD ,_, B_NNP *_NN 0801_CD ,_, B_NNP *_NN 2705_CD ,_,
        B_NNP *_NN 3501_CD ,_, B_NNP *_NN 5301_CD ,_, H-_NNP 2_CD K_NN B_NNP ,_, H-_NNP 2_CD D_NNP B_NNP ,_, H-_NNP 2_CD D_NNP D_NNP ,_, H-_NNP 2_CD L_NNP D_NNP ,_, DR_NNP 1_CD ,_, DR_NNP 2_CD ,_,
        DR_NNP 3_CD ,_, DR_NNP 4_CD ,_, I-A_NNP DMHC-peptide_NNP crystal_NN complexes_NNS are_VBP available_JJ
        in_IN the_DT PDB_NNP ._. A_DT comprehensive_JJ report_NN mapping_NN MHC_NNP sequences_NNS
        with_IN X-_NNP ray_NN crystal_NN structures_NNS and_CC relative_JJ binding_JJ strength_NN
        is_VBZ available_JJ ._. [_NN 32_CD ]_NN Recently_RB ,_, Cano_NNP and_CC Fan_NNP conceptualized_JJ
        peptide_NN binding_JJ to_TO MHC_NNP by_IN algebraic_JJ and_CC geometric_JJ
        frameworks_NNS using_VBG structural_JJ data_NNS ._. [_NN 33_CD ]_NN All_DT MHC_NNP alleles_NNS
        have_VBP more_JJR than_IN 70_CD %_NN sequence_NN identity_NN with_IN known_VBN MHC_NNP
        structures_NNS ._. [_NN 25_CD ]_NN This_DT allows_VBZ structure_NN prediction_NN for_IN the_DT
        known_VBN 1_CD ,_, 500_CD HLA_NNP sequences_NNS [_NN 34_CD ]_NN using_VBG known_VBN templates_NNS ._. [_NN
        25_CD ]_NN Currently_RB ,_, accurate_JJ prediction_NN of_IN peptide_NN structures_NNS
        in_IN the_DT MHC_NNP groove_NN is_VBZ not_RB reliable_JJ due_NN to_TO the_DT limited_JJ
        availability_NN of_IN peptide_NN backbone_NN templates_NNS and_CC the_DT
        shortcomings_NNS in_IN the_DT existing_VBG peptide_NN backbone_NN prediction_NN
        methods_NNS ._. Using_VBG independent_JJ procedures_NNS ,_, Schuler_NNP et_CC al_NN ._. ,_, [_NN 21_CD
        22_CD ]_NN and_CC Rognan_NNP et_CC al_NN ._. [_NN 23_CD ]_NN have_VBP demonstrated_VBN a_DT method_NN
        for_IN peptide_NN backbone_NN selection_NN and_CC showed_VBD a_DT reasonable_JJ
        improvement_NN in_IN the_DT MHC-peptide_NNP binding_JJ prediction_NN ._. [_NN 21_CD 22_CD
        23_CD ]_NN An_DT accurate_JJ prediction_NN of_IN the_DT peptide_NN structure_NN in_IN the_DT
        groove_NN can_MD be_VB achieved_VBN through_IN the_DT appropriate_JJ selection_NN of_IN
        backbone_NN templates_NNS for_IN threading_VBG or_CC side_NN chain_NN packing_NN ._. The_DT
        critical_JJ nature_NN of_IN the_DT backbone_NN conformation_NN that_WDT affects_VBZ
        MHC-peptide_NNP binding_JJ will_MD be_VB interesting_JJ to_TO investigate_VB ._. The_DT
        nature_NN of_IN inter-atomic_JJ interactions_NNS at_IN the_DT MHC-peptide_NNP
        interface_NN has_VBZ been_VBN studied_VBN for_IN individual_JJ complexes_NNS by_IN
        protein_NN crystallographers_NNS ._. However_RB ,_, there_EX is_VBZ no_DT
        comprehensive_JJ report_NN available_JJ describing_VBG the_DT common_JJ types_NNS
        of_IN interactions_NNS in_IN a_DT set_NN of_IN MHC-peptide_NNP complexes_NNS
        characterized_VBN by_IN MHC_NNP allele_NN variation_NN and_CC peptide_NN sequence_NN
        diversity_NN ._. The_DT objective_NN of_IN this_DT study_NN is_VBZ to_TO find_VB which_WDT
        types_NNS of_IN inter-atomic_JJ interactions_NNS contribute_VBP more_JJR in_IN
        defining_VBG the_DT binding_JJ between_IN peptides_NNS and_CC MHC_NNP
        molecules_NNS ._.
      
      
        Results_NNS
        The_DT available_JJ data_NN in_IN the_DT PDB_NNP are_VBP redundant_JJ and_CC hence_RB we_PRP
        created_VBD a_DT non-redundant_JJ set_VBN from_IN those_DT entries_NNS with_IN the_DT
        best_JJS resolution_NN for_IN the_DT related_VBN structural_JJ complexes_NNS having_VBG
        identical_JJ sequence_NN information_NN ._. The_DT non-redundant_JJ dataset_NN
        consists_VBZ of_IN twenty-eight_JJ class_NN I_PRP MHC-Peptide_NNP complexes_NNS and_CC
        ten_CD class_NN II_NNP MHC-peptide_NNP complexes_NNS ._. All_DT the_DT complexes_NNS
        chosen_VBN for_IN the_DT study_NN are_VBP characterized_VBN by_IN variation_NN in_IN
        sequences_NNS constituting_VBG the_DT MHC-peptide_NNP complexes_NNS ._. The_DT
        binding_JJ of_IN MHC_NNP and_CC peptide_NN can_MD be_VB described_VBN using_VBG
        inter-atomic_JJ interactions_NNS based_VBN on_IN backbone_NN and_CC sidechain_NN
        atom_NN preference_NN at_IN their_PRP$ interface_NN ._.
        We_PRP calculated_VBD the_DT percentage_NN prominence_NN for_IN each_DT of_IN the_DT
        four_CD types_NNS of_IN interactions_NNS (_( BB_NNP ,_, SS_NNP ,_, BS_NNP and_CC SB_NNP )_) at_IN the_DT
        interface_NN of_IN these_DT complexes_NNS (_( Figures_NNS 1_CD and_CC 2_LS )_) ._. The_DT backbone_NN
        or_CC sidechain_NN atom_NN preference_NN at_IN the_DT interface_NN induced_VBN by_IN
        MHC-peptide_NNP sequence_NN variation_NN is_VBZ estimated_VBN by_IN calculating_VBG
        the_DT mean_JJ percentage_NN for_IN each_DT type_NN in_IN the_DT dataset_NN (_( Figures_NNS
        3_CD and_CC 4_LS )_) ._. The_DT preferences_NNS for_IN the_DT interaction_NN types_NNS are_VBP
        found_VBN to_TO be_VB similar_JJ between_IN complexes_NNS but_CC not_RB identical_JJ
        (_( Figures_NNS 1_CD and_CC 2_LS )_) ._. Therefore_RB ,_, we_PRP calculated_VBD the_DT standard_JJ
        deviation_NN about_IN the_DT mean_JJ percentage_NN preference_NN for_IN each_DT of_IN
        the_DT interaction_NN types_NNS in_IN both_DT the_DT data_NN sets_NNS (_( Figures_NNS 5_CD and_CC
        6_CD )_) ._.
        SS_NNP and_CC SB_NNP interactions_NNS are_VBP prevalent_JJ compared_VBN to_TO the_DT
        other_JJ two_CD types_NNS (_( Figures_NNS 3_CD and_CC 4_LS )_) ._. This_DT observation_NN is_VBZ true_JJ
        for_IN both_DT class_NN I_PRP and_CC class_NN II_NNP MHC-peptide_NNP complexes_NNS ._. SB_NNP
        interactions_NNS are_VBP prevalent_JJ than_IN SS_NNP interactions_NNS at_IN 3_CD Å_NN
        cut-off_JJ distance_NN in_IN these_DT molecules_NNS ._. From_IN 3_CD ._. 5_CD -_: 6_CD Å_NN SS_NNP
        interactions_NNS dominate_VBP over_IN SB_NNP interactions_NNS in_IN class_NN I_PRP
        complexes_NNS ._. At_IN inter-atomic_JJ distances_NNS greater_JJR than_IN 6_CD Å_NN ,_, SS_NNP
        and_CC SB_NNP interactions_NNS are_VBP just_RB as_IN prevalent_JJ ._. However_RB ,_, SB_NNP
        interactions_NNS are_VBP relatively_RB dominant_JJ over_IN SS_NNP in_IN class_NN II_NNP
        complexes_NNS ._.
        SS_NNP and_CC SB_NNP interactions_NNS are_VBP influenced_VBN by_IN MHC_NNP sequence_NN
        polymorphism_NN and_CC peptide_NN sequence_NN diversity_NN ._. The_DT mean_JJ
        percentage_NN distribution_NN is_VBZ maximum_NN at_IN an_DT inter-atomic_JJ
        distance_NN of_IN 3_CD Å_NN for_IN SS_NNP and_CC SB_NNP interactions_NNS (_( Figures_NNS 3_CD and_CC 4_LS )_) ._.
        However_RB ,_, the_DT distribution_NN of_IN standard_JJ deviation_NN remains_VBZ at_IN
        a_DT maximum_NN for_IN inter-atomic_JJ distance_NN ranges_NNS of_IN 2_CD -_: 3_CD Å_NN in_IN both_DT
        the_DT classes_NNS of_IN MHC-peptide_NNP complexes_NNS (_( Figures_NNS 5_CD and_CC 6_CD )_) ._. The_DT
        standard_JJ deviation_NN for_IN SB_NNP type_NN interactions_NNS is_VBZ the_DT highest_JJS
        in_IN these_DT complexes_NNS and_CC this_DT explains_VBZ the_DT sequence_NN induced_VBD
        variation_NN in_IN peptide_NN backbone_NN /_NN MHC_NNP sidechain_NN atom_NN preference_NN
        during_IN MHC-peptide_NNP binding_JJ ._. The_DT sequence_NN induced_VBD deviation_NN
        for_IN inter-atomic_JJ interactions_NNS is_VBZ also_RB observed_VBN for_IN SS_NNP in_IN
        class_NN I_PRP complexes_NNS ._. It_PRP is_VBZ interesting_JJ to_TO note_VB that_IN the_DT
        presence_NN of_IN BB_NNP and_CC BS_NNP interactions_NNS in_IN these_DT complexes_NNS is_VBZ
        limited_JJ compared_VBN to_TO the_DT other_JJ two_CD types_NNS and_CC the_DT standard_JJ
        deviation_NN is_VBZ also_RB minimal_JJ (_( Figures_NNS 3_CD and_CC 4_LS )_) ._. Our_PRP$ results_NNS
        explain_VBP the_DT consistent_JJ prevalence_NN of_IN SS_NNP and_CC SB_NNP interactions_NNS
        at_IN the_DT MHC-peptide_NNP interface_NN ._.
      
      
        Discussion_NNP
        The_DT differential_NN binding_JJ of_IN peptides_NNS to_TO diverse_JJ MHC_NNP
        molecules_NNS during_IN cell-mediated_JJ immune_JJ response_NN has_VBZ been_VBN
        fairly_RB established_VBN using_VBG MHC-peptide_NNP structural_JJ data_NNS
        obtained_VBN by_IN X-_NNP ray_NN crystallography_NN ._. [_NN 32_CD 35_CD 38_CD ]_NN The_DT
        available_JJ biochemical_JJ binding_JJ data_NNS obtained_VBN by_IN kinetic_JJ
        studies_NNS [_NN 36_CD 37_CD ]_NN complements_VBZ the_DT structural_JJ explanation_NN
        for_IN MHC-peptide_NNP binding_JJ ._. [_NN 32_CD 35_CD 38_CD ]_NN The_DT structural_JJ
        similarity_NN between_IN known_VBN MHC_NNP alleles_NNS allows_VBZ for_IN side-chain_JJ
        prediction_NN procedures_NNS to_TO be_VB carried_VBN out_IN for_IN other_JJ MHC_NNP
        molecules_NNS using_VBG available_JJ structural_JJ templates_NNS ._. [_NN 25_CD 39_CD ]_NN
        However_RB ,_, model_NN building_NN of_IN a_DT user_NN defined_VBD peptide_NN sequence_NN
        in_IN the_DT groove_NN using_VBG sidechain_NN packing_VBG techniques_NNS requires_VBZ
        reliable_JJ backbone_NN templates_NNS ._. The_DT prediction_NN of_IN allele_NN
        specific_JJ peptide_NN structures_NNS depends_VBZ on_IN the_DT selection_NN of_IN
        peptide_NN backbone_NN from_IN a_DT template_NN library_NN ._. [_NN 21_CD ]_NN The_DT root_NN
        mean_NN square_JJ deviation_NN for_IN peptide_NN backbone_NN atoms_NNS (_( N_NNP ,_, Cα_NNP ,_, C_NNP
        and_CC O_NNP )_) lies_VBZ within_IN 2_CD ._. 1_CD Å_NN among_IN structure_NN groups_NNS based_VBN on_IN
        allele_NN specificity_NN and_CC peptide_NN length_NN ._. [_NN 21_CD ]_NN Thus_RB ,_, it_PRP is_VBZ
        possible_JJ to_TO select_VB the_DT most_RBS appropriate_JJ peptide_NN backbone_NN
        template_NN for_IN predicting_VBG the_DT structure_NN of_IN a_DT user_NN defined_VBD
        peptide_NN sequence_NN in_IN the_DT groove_NN ._. In_IN this_DT approach_NN ,_, the_DT
        peptide_NN structure_NN in_IN the_DT groove_NN is_VBZ constructed_VBN by_IN threading_VBG
        and_CC its_PRP$ compatibility_NN to_TO bind_NN is_VBZ evaluated_VBN by_IN statistical_JJ
        pair-wise_JJ potentials_NNS ._. [_NN 21_CD 22_CD ]_NN These_DT pair-wise_JJ potential_JJ
        tables_NNS emphasize_VBP either_CC hydrophobic_JJ [_NN 40_CD 41_CD ]_NN or_CC
        hydrophilic_JJ interactions_NNS [_NN 42_CD ]_NN at_IN the_DT interface_NN ._. The_DT
        efficient_JJ prediction_NN of_IN peptide_NN side-chain_JJ conformations_NNS in_IN
        the_DT groove_NN has_VBZ been_VBN shown_VBN mainly_RB due_JJ to_TO van_NN der_NNP Waals_NNP
        contribution_NN ._. [_NN 21_CD ]_NN An_DT independent_JJ study_NN used_VBD a_DT simple_JJ and_CC
        fast_RB free_JJ energy_NN function_NN (_( Fresno_NNP )_) to_TO predict_VB the_DT binding_JJ
        free_JJ energies_NNS of_IN peptides_NNS to_TO class_NN I_PRP MHC_NNP proteins_NNS ._. [_NN 23_CD ]_NN
        This_DT was_VBD based_VBN on_IN the_DT explicit_JJ treatment_NN of_IN ligand_NN
        desolvation_NN and_CC unfavorable_JJ MHC_NNP protein-peptide_JJ contacts_NNS ._. A_DT
        similar_JJ binding_JJ /_NN non-binding_JJ grouping_VBG scheme_NN was_VBD based_VBN on_IN
        vdWC_NN and_CC SEHPR_NNP ._. [_NN 25_CD ]_NN Despite_IN sufficient_JJ knowledge_NN on_IN the_DT
        chemical_NN nature_NN of_IN molecular_JJ interactions_NNS very_RB little_JJ is_VBZ
        known_VBN about_IN the_DT common_JJ interaction_NN types_NNS for_IN MHC-peptide_NNP
        complexes_NNS ._. Here_RB ,_, we_PRP present_VB the_DT distribution_NN of_IN four_CD types_NNS
        of_IN inter-atomic_JJ interactions_NNS between_IN MHC_NNP and_CC peptide_NN ._. SS_NNP
        and_CC SB_NNP interactions_NNS are_VBP commonly_RB found_VBN at_IN the_DT interface_NN of_IN
        these_DT complexes_NNS ._. This_DT implies_VBZ that_IN the_DT backbone_NN atoms_NNS in_IN
        the_DT MHC_NNP molecules_NNS play_VBP a_DT secondary_JJ role_NN in_IN the_DT binding_VBG of_IN
        the_DT peptide_NN ;_: it_PRP is_VBZ the_DT interaction_NN between_IN the_DT sidechain_NN
        atoms_NNS in_IN the_DT MHC_NNP molecules_NNS with_IN both_DT side-chain_JJ and_CC
        backbone_NN atoms_NNS in_IN the_DT peptide_NN what_WP determines_VBZ the_DT binding_JJ ._.
        Success_NNP in_IN peptides_NNS designed_VBN to_TO bind_NN in_IN the_DT MHC_NNP groove_NN has_VBZ
        been_VBN achieved_VBN by_IN carefully_RB dissecting_VBG side_NN chain_NN
        interactions_NNS and_CC placing_VBG appropriate_JJ flexible_JJ residues_NNS at_IN
        key_JJ positions_NNS in_IN the_DT peptide_NN ._. Hence_RB ,_, SS_NNP interactions_NNS are_VBP
        crucial_JJ for_IN proper_JJ anchoring_VBG of_IN short_JJ peptides_NNS within_IN the_DT
        groove_NN ._. The_DT SB_NNP interactions_NNS might_MD facilitate_VB an_DT induced_VBN fit_NN
        of_IN the_DT peptide_NN during_IN entry_NN into_IN the_DT groove_NN ._. The_DT backbone_NN
        conformation_NN adopted_VBN by_IN the_DT peptide_NN in_IN the_DT groove_NN is_VBZ
        important_JJ for_IN maintaining_VBG the_DT predominantly_RB common_JJ SB_NNP
        interactions_NNS ._. Specific_JJ interactions_NNS by_IN peptide_NN sidechain_NN
        atoms_NNS inside_IN the_DT groove_NN may_MD force_VB its_PRP$ backbone_NN to_TO adopt_VB a_DT
        suitable_JJ conformation_NN for_IN maximal_NN interactions_NNS with_IN the_DT
        receptor_NN atoms_NNS ._.
      
      
        Conclusions_NNP
        The_DT current_JJ challenge_NN in_IN MHC-peptide_NNP binding_JJ prediction_NN
        is_VBZ twofold_NN :_: (_( 1_LS )_) accurate_JJ prediction_NN of_IN peptide_NN backbone_NN
        conformation_NN for_IN subsequent_JJ sidechain_NN packing_VBG (_( 2_LS )_) accurate_JJ
        estimation_NN of_IN function_NN by_IN such_JJ predictions_NNS for_IN quantitative_JJ
        MHC-peptide_NNP binding_JJ studies_NNS ._. Much_JJ of_IN our_PRP$ earlier_JJR
        understanding_NN on_IN protein-ligand_JJ interactions_NNS is_VBZ based_VBN on_IN
        the_DT steric_JJ factors_NNS ,_, electrostatic_JJ contributions_NNS ,_,
        hydrophobicity_NN ,_, hydrogen-bond_JJ donor_NN or_CC acceptor_NN capability_NN ._.
        Our_PRP$ results_NNS show_VBP the_DT prevalence_NN of_IN backbone_NN or_CC sidechain_NN
        atom_NN preference_NN at_IN the_DT MHC-peptide_NNP interface_NN characterized_VBN
        by_IN varying_VBG sequence_NN composition_NN ._. The_DT prevalence_NN of_IN SB_NNP
        interactions_NNS in_IN these_DT complexes_NNS suggests_VBZ the_DT importance_NN of_IN
        peptide_NN backbone_NN conformation_NN during_IN MHC-peptide_NNP binding_JJ ._.
        The_DT currently_RB available_JJ protein_NN structure_NN prediction_NN
        algorithms_NNS are_VBP well_RB developed_VBN for_IN protein_NN sidechain_NN packing_VBG
        upon_IN fixed_VBN backbone_NN templates_NNS ._. This_DT study_NN shows_VBZ the_DT
        prevalence_NN of_IN backbone_NN atoms_NNS in_IN MHC-peptide_NNP binding_JJ and_CC
        hence_RB highlights_VBZ the_DT need_NN for_IN accurate_JJ peptide_NN backbone_NN
        prediction_NN in_IN quantitative_JJ MHC-peptide_NNP binding_JJ estimation_NN
        using_VBG molecular_JJ mechanics_NNS calculations_NNS ._. Development_NNP of_IN an_DT
        efficient_JJ energy_NN function_NN for_IN the_DT accurate_JJ prediction_NN of_IN
        both_DT backbone_NN and_CC side-chain_JJ conformations_NNS followed_VBN by_IN an_DT
        effective_JJ MHC-peptide_NNP interaction_NN function_NN will_MD help_VB to_TO
        quantify_VB the_DT differences_NNS in_IN peptide_NN binding_JJ caused_VBN by_IN MHC_NNP
        polymorphism_NN and_CC peptide_NN diversity_NN ._. It_PRP should_MD be_VB noted_VBN that_IN
        the_DT conclusions_NNS reached_VBN in_IN this_DT article_NN are_VBP based_VBN on_IN the_DT
        available_JJ crystal_NN data_NNS ._. Additional_JJ data_NNS will_MD be_VB required_VBN to_TO
        confirm_VB the_DT proposed_VBN hypothesis_NNS ._. If_IN the_DT efficiency_NN of_IN
        MHC-peptide_NNP binding_JJ prediction_NN is_VBZ carefully_RB assessed_VBN for_IN
        routine_JJ application_NN then_RB identification_NN of_IN T-_NNP cell_NN epitopes_NNS
        from_IN sequence_NN information_NN will_MD become_VB easier_JJR ._. Apart_RB from_IN
        peptide_NN MHC_NNP specificity_NN many_JJ other_JJ important_JJ parameters_NNS
        that_WDT describe_VBP cellular_JJ mechanisms_NNS such_JJ as_IN enzyme-mediated_JJ
        antigen_NN processing_NN ,_, peptide_NN transport_NN ,_, loading_NN of_IN peptides_NNS
        to_TO MHC_NNP molecules_NNS and_CC the_DT phenomenon_NN of_IN TCR_NNP repertoires_NNS have_VBP
        to_TO be_VB identified_VBN and_CC incorporated_VBN into_IN the_DT prediction_NN
        framework_NN ._.
      
      
        Methods_NNP and_CC materials_NNS
        
          MHC-peptide_NNP X-_NNP ray_NN crystal_NN data_NNS
          X-_NNP ray_NN crystal_NN data_NNS for_IN MHC-peptide_NNP complexes_NNS are_VBP
          retrieved_VBN from_IN Protein_NNP Databank_NNP (_( PDB_NNP )_) (_(
          www_NN ._. rcsb_NN ._. org_NN /_NN pdb_NN /_NN )_) ._. If_IN more_JJR than_IN one_CD entry_NN described_VBD an_DT
          identical_JJ combination_NN of_IN MHC_NNP and_CC peptide_NN sequence_NN
          information_NN we_PRP selected_VBD the_DT entry_NN with_IN the_DT best_JJS atomic_JJ
          resolution_NN (_( Å_NN )_) ._. We_PRP identified_VBD 28_CD non-redundant_JJ class_NN I_PRP
          MHC-peptide_NNP complexes_NNS (_( Table_NNP 1_LS )_) and_CC 10_CD non-redundant_JJ
          class_NN II_NNP MHC-peptide_NNP complexes_NNS (_( Table_NNP 2_LS )_) ._. The_DT two_CD sets_NNS of_IN
          crystal_NN complexes_NNS are_VBP examined_VBN for_IN the_DT different_JJ types_NNS of_IN
          inter-atomic_JJ interactions_NNS at_IN the_DT interface_NN ._.
        
        
          Data_NNP analysis_NN
          
            Inter-atomic_NNP interactions_NNS at_IN the_DT MHC-peptide_NNP
            Interface_NNP
            The_DT interactions_NNS between_IN MHC_NNP and_CC peptide_NN are_VBP studied_VBN
            by_IN measuring_VBG the_DT distance_NN between_IN each_DT atom_NN in_IN the_DT MHC_NNP
            and_CC each_DT atom_NN in_IN the_DT peptide_NN ._. An_DT atom_NN in_IN a_DT MHC_NNP residue_NN
            or_CC a_DT peptide_NN residue_NN is_VBZ considered_VBN to_TO be_VB involved_VBN in_IN
            MHC-peptide_NNP binding_VBG if_IN the_DT distance_NN between_IN any_DT atom_NN of_IN
            the_DT peptide_NN and_CC any_DT atom_NN of_IN the_DT MHC_NNP is_VBZ less_JJR than_IN or_CC
            equal_JJ to_TO x_SYM (_( Å_NN )_) ._. The_DT value_NN of_IN x_SYM is_VBZ varied_VBN from_IN 0_CD ._. 0_CD to_TO
            10_CD ._. 0_CD (_( Å_NN )_) at_IN increments_NNS of_IN 0_CD ._. 1_CD (_( Å_NN )_) ._. The_DT total_JJ number_NN of_IN
            inter-atomic_JJ interactions_NNS at_IN every_DT value_NN of_IN x_SYM is_VBZ
            grouped_VBN into_IN four_CD different_JJ types_NNS based_VBN on_IN backbone_NN and_CC
            sidechain_NN atom_NN preference_NN between_IN MHC_NNP and_CC peptide_NN ._. Four_CD
            types_NNS of_IN inter-atomic_JJ interactions_NNS namely_RB ,_, BB_NNP (_( backbone_NN
            MHC_NNP -_: backbone_NN peptide_NN )_) ,_, SS_NNP (_( sidechain_NN MHC_NNP -_: sidechain_NN
            peptide_NN )_) ,_, BS_NNP (_( backbone_NN MHC_NNP -_: sidechain_NN peptide_NN )_) and_CC SB_NNP
            (_( sidechain_NN MHC_NNP -_: backbone_NN peptide_NN )_) characterize_VB the_DT
            MHC-peptide_NNP interface_NN based_VBN on_IN backbone_NN and_CC sidechain_NN
            atom_NN preference_NN ._.
          
          
            Percentage_NN distribution_NN for_IN the_DT interaction_NN
            types_NNS
            Percentage_NN distribution_NN for_IN the_DT interaction_NN types_NNS is_VBZ
            defined_VBN as_IN the_DT percentage_NN of_IN each_DT interaction_NN type_NN over_IN
            all_DT interactions_NNS for_IN a_DT given_VBN inter-atomic_JJ distance_NN ._.
          
        
      
      
        List_NN of_IN abbreviations_NNS
        ANN_NNP =_SYM artificial_JJ neural_NN network_NN
        BB_NNP =_SYM backbone_NN MHC_NNP -_: backbone_NN peptide_NN
        BS_NNP =_SYM backbone_NN MHC_NNP -_: sidechain_NN peptide_NN
        EBNA_NNP =_SYM Epstein_NNP Barr_NNP nuclear_JJ antigen_NN
        EBV_NNP =_SYM Epstein_NNP Barr_NNP virus_NN
        GvHD_NNP =_SYM graft_NN vs_NNS host_NN disease_NN
        HA_NNP =_SYM hemagglutinin_NN
        HBV_NNP =_SYM hepatitis_NNP B_NNP virus_NN
        HIV_NNP =_SYM human_JJ immunodeficiency_NN virus_NN
        HMBP_NNP =_SYM human_JJ myelin_NN basic_JJ protein_NN
        HMM_NNP =_SYM hidden_VBN Markov_NNP model_NN
        HTLV_NNP =_SYM human_JJ T_NN lymphotropic_JJ virus_NN
        mHag_NN =_SYM minor_JJ histocompatibility_NN antigen_NN
        MHC_NNP =_SYM major_JJ histocompatibility_NN complex_JJ
        PDB_NNP =_SYM protein_NN databank_NN
        vdWC_NN =_SYM van_NN der_NNP Waals_NNP Clash_NNP
        RT_NNP =_SYM reverse_VB transcriptase_NN
        SB_NNP =_SYM sidechain_NN MHC_NNP -_: backbone_NN peptide_NN
        SEHPR_NNP =_SYM solvent_JJ exposed_VBN hydrophobic_JJ peptide_NN residues_NNS
        SS_NNP =_SYM sidechain_NN MHC_NNP -_: sidechain_NN peptide_NN
        SV_NNP =_SYM Sendai_NNP virus_NN
        Vsv_NNP =_SYM vesicular_NN stomatitis_NNS virus_NN
      
    
  
